We are live on ! Find out more
SYRS icon

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$29.5M +$9.92K +245 +0%
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$20.4M +$1.94M +47,938 +8%
BlackRock
3
BlackRock
New York
$13.8M -$492K -12,140 -3%
ABG
4
Ally Bridge Group
New York
$11.5M +$405K +10,000 +3%
AG
5
Artal Group
Luxembourg
$9.78M +$4.05M +100,000 +50%
FP
6
Flagship Pioneering
Massachusetts
$9.58M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$9.1M -$792K -19,561 -7%
OFM
8
Omega Fund Management
Massachusetts
$8.19M – – –
SB
9
Samsara BioCapital
California
$6.24M – – –
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$6.19M +$405K +10,000 +6%
OrbiMed
11
OrbiMed
New York
$5.99M – – –
ACM
12
Altium Capital Management
New York
$3.78M -$455K -11,241 -9%
State Street
13
State Street
Massachusetts
$3.75M +$135K +3,337 +3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.11M +$387K +9,555 +11%
SCM
15
Sio Capital Management
New York
$2.94M – – –
RA Capital Management
16
RA Capital Management
Massachusetts
$2.93M – – –
Candriam SCA
17
Candriam SCA
Luxembourg
$1.91M – – –
Northern Trust
18
Northern Trust
Illinois
$1.71M +$810 +20 +0%
LCP
19
LGT Capital Partners
Switzerland
$1.63M +$1.85M +45,661 +1,052%
Goldman Sachs
20
Goldman Sachs
New York
$1.61M +$17.8K +439 +0.9%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$1.03M +$445K +10,990 +54%
Los Angeles Capital Management
22
Los Angeles Capital Management
California
$840K -$5.06K -125 -0.5%
GCP
23
GSA Capital Partners
United Kingdom
$789K +$534K +13,179 +119%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$633K -$8.5K -210 -1%
Nuveen
25
Nuveen
North Carolina
$611K -$72.8K -1,799 -9%